// App-Quantinova.ai

1117-319 : THROMBOEMBOLISM PROPHYLAXIS IN FONTAN PATIENTS. WHAT SHOULD WE USE? A META-ANALYSIS OF PUBLISHED TRIALS

Researchers

Presenter

  • Said Alsidawi

Principal Investigators

  • Tarek Alsaied

  • Gruschen Veldtman

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Warfarin

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved